June 19, 2017
Health Canada approves Horizon Pharma’s nephropathic cystinosis drug
Health Canada has issued a Notice of Compliance (NOC) for Horizon Pharma’s Procysbi (cysteamine delayed-release capsules) for the treatment of nephropathic cystinosis in adults and children 2 years of age and older.